SCHEDULE: FMR LLC Discloses 5.1% Stake in Boston Scientific

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 5.1% of Boston Scientific Corp.'s common stock as of March 31, 2026.

Summary

• FMR LLC and Abigail P. Johnson have filed a Schedule 13G, indicating their beneficial ownership of Boston Scientific Corp. common stock.
• As of March 31, 2026, the total beneficial ownership reported is 75,835,683.30 shares, representing 5.1% of the class.
• FMR LLC, a Delaware entity, holds the majority of the reported shares, with Abigail P. Johnson, a U.S. citizen, also listed as a reporting person.
• The filing indicates that FMR LLC is an investment adviser (IA) and Abigail P. Johnson is an insider (IN) for reporting purposes.
• Several subsidiaries of FMR LLC, including Crosby Advisors LLC, FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Management & Research Company LLC, and Strategic Advisers LLC, are identified as entities that beneficially own shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not provide new operational or financial information about Boston Scientific.

Positives

• FMR LLC and Abigail P. Johnson maintain a significant stake in Boston Scientific, suggesting continued confidence in the company's prospects.
• The filing is an amendment to a previous filing, indicating ongoing monitoring and reporting of ownership stakes.

Risks

• The filing does not contain specific forward-looking statements or risk factors related to Boston Scientific's business operations, as it is primarily an ownership disclosure.
• Potential future changes in FMR LLC's or Abigail P. Johnson's ownership stake could impact the market perception of Boston Scientific.

Future Outlook

This filing is an update to ownership disclosure and does not contain specific forward-looking statements or guidance from Boston Scientific Corp. regarding its future business or financial performance.

Industry Context

StockSavvy.ai notes that significant institutional ownership, as reported by FMR LLC, is a common indicator of investor confidence in the medical device sector, where Boston Scientific operates. Such filings are crucial for understanding the major holders of a company's stock.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding significant institutional ownership, which can influence investor sentiment and market perception.
• Management of Boston Scientific Corp.: Awareness of major shareholders like FMR LLC is important for corporate strategy and investor relations.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to monitor their beneficial ownership of Boston Scientific Corp. common stock and file amendments as required by SEC regulations.

Key Dates

Keywords

Boston Scientific, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Ownership Stake